glp-1 before after Body Image Distortion Weight Loss Common With Drugs: Experts GLP-1 Weight Loss Injections in

Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis

Hendershot, C

Look for documented strains over generic blends if metabolic support is your intent

It has passed phase 1 and 2 clinical trials and is currently in phase 3 trials, with an expected launch in 2026 or 2027 if approved

2, what pharmacy is it coming from and whats the oversight there

Interest stems mainly from their metabolic and weight-management effects, but robust human clinical trial evidence supporting direct thyroid or autoimmune benefits is lacking